By Dennis Thompson HealthDay ReporterFRIDAY, June 5, 2026 (HealthDay News) — An already available two-pill combo treats ...
The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia ...
New research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational ...
Researchers sought to determine whether adding selinexor to chemotherapeutic induction and consolidation regimen would improve outcomes in AML.
SOUTH SAN FRANCISCO, Calif. & HEIDELBERG, Germany, June 03, 2026--Mission Bio, a leader in single-cell multiomics, jointly ...
Hosted on MSN
What To Know About Acute Myelogenous Leukemia (AML)
Acute myelogenous leukemia (AML), also known as acute myeloid leukemia, is a type of cancer that starts in your bone marrow (the soft, spongy tissue inside the bones that makes blood cells). AML is ...
A case of acute myeloid leukemia with mast cell differentiation (AML-MC) that subsequently fulfilled diagnostic criteria for mast cell leukemia (MCL), an aggressive type of systemic mastocytosis (SM), ...
Relapsed acute myeloid leukemia (AML) is when cancer returns after a period of remission. Refractory AML means cancer has not responded to multiple rounds of treatment. Both can affect your treatment ...
I think probably the best one is the urban patient who has access to an academic medical center that is running clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results